Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M

Login to View

Tencent-backed healthcare firm WeDoctor Group, Hong Kong-listed financial services company Mason Group and Asian investment firm Aldworth Management will reportedly team up to acquire Australian fertility treatment firm Genea for an estimated HKD4 billion (about US$509 million), according to media reports.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Read 3 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription for $359

Enjoy comprehensive and exclusive data you can't find elsewhere!

Subscribe for $359

Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in

China Money Network Subscription